Antibody-Mediated Rejection of Solid-Organ Allografts This review focuses on current
standards for management of antibody-mediated rejection in solid-organ transplant …

Liver allograft rejection remains a significant cause of morbidity and graft failure in liver
transplant recipients. Rejection is caused by the recognition of non-self donor alloantigens …

The Banff Working Group on Liver Allograft Pathology reviewed and discussed literature
evidence regarding antibody-mediated liver allograft rejection at the 11th (Paris, France …

Abstract Although anti–HLA (Human Leukocyte Antigen) donor-specific antibodies (DSAs)
are commonly measured in clinical practice and their relationship with transplant outcome is …

The past three decades have seen liver transplantation becoming a major therapeutic
approach in the management of end-stage liver diseases. This is due to the dramatic …

Solid organ transplantation is a curative therapy for hundreds of thousands of patients with
end-stage organ failure. However, long-term outcomes have not improved, and nearly half of …

Antibody-mediated rejection after liver transplantation is an under-recognised cause of
allograft injury. While definitions of acute and chronic antibody-mediated rejection have …

The pathophysiology of antibody-mediated rejection (AMR) in solid organ transplants is
multifaceted and predominantly caused by antibodies directed against polymorphic donor …

Donor-specific alloantibodies (DSA) can cause acute antibody-mediated rejection (AMR) in
all solid organ allografts. However, long-term outcome in patients with posttransplant DSA …

Liver transplantation, although now a routine procedure, with defined indications and
usually excellent outcomes, still has challenges. Donor shortage remains a key issue …